Exploring metabolic dysfunction in chronic kidney disease. - Wikidata - awgldk - TriplyDB

Exploring metabolic dysfunction in chronic kidney disease.

Exploring metabolic dysfunction in chronic kidney disease.

http://www.wikidata.org/entity/Q36123347

about

Insulin resistance in patients with chronic kidney disease Mitochondria: a new therapeutic target in chronic kidney disease Mechanism of insulin resistance in a rat model of kidney disease and the risk of developing type 2 diabetes.Dietary Lycium barbarum polysaccharide induces Nrf2/ARE pathway and ameliorates insulin resistance induced by high-fat via activation of PI3K/AKT signaling.Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3 Integrative biology identifies shared transcriptional networks in CKD.Atomoxetine prevents dexamethasone-induced skeletal muscle atrophy in mice A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients Association between the dietary factors and metabolic syndrome with chronic kidney disease in Chinese adults Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis.Regulation of muscle protein synthesis and the effects of catabolic states.Proteomic and phosphoproteomic analysis of renal cortex in a salt-load rat model of advanced kidney damage.Metabolic syndrome and associated chronic kidney diseases: nutritional interventions.Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease.Disentangling the Impact of Chronic Kidney Disease, Anemia, and Mobility Limitation on Mortality in Older Patients Discharged From Hospital.Proteinuria and its relation to diverse biomarkers and body mass index in chronic hemodialysis.Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease.Inflammatory and Metabolic Syndrome Biomarker Analysis of Vascular Outcomes in End-stage Renal Disease.Malnutrition in Chronic Kidney Disease.Inadequate dietary energy intake associates with higher prevalence of metabolic syndrome in different groups of hemodialysis patients: a clinical observational study in multiple dialysis centers

P2860

Q21285003-FF5B679D-E340-4202-B51E-2B5E0ECCF7CE Q26776397-6A0B718A-0E23-451E-9ECD-AE71EE5C08A0 Q33620761-DEF924F1-78EE-4FF7-8A5E-710CFDF30405 Q33871538-C8DB94CA-0EFA-4A66-AFBF-D467F218AD15 Q34021434-8273FA43-5E55-4D3E-AD29-DAC849281074 Q34427636-4380DD32-8942-4C5D-B241-A7208CA96270 Q34573906-9DEE2B44-A82A-47EF-AED3-F858C22647EC Q34714685-5B41D016-F67A-4330-91CD-D2AF4B01F225 Q34770072-B3EA4F32-A5DA-4511-A2F4-0B09EDAAAB31 Q34816064-23F4A900-6123-40DA-B359-1C8F109E8F57 Q35208558-3F6AFA80-3209-407F-9C15-5A25CA237D62 Q37016642-4B86D515-20BD-46D3-9073-5B5153EC9E4B Q37138209-43548C42-A8E1-42BD-B4B4-BB154515EEAC Q37360338-77816F33-8975-4627-85FF-16691D5BE093 Q38137667-895E52CC-0942-47FC-B5C1-34C22098A025 Q40618492-385106A0-95BD-4B9B-B57B-9D2BF40EABD4 Q41498133-BBAFA22A-F0DE-444D-BA99-863037557629 Q41727432-EB94C00A-6E1D-43C6-8CEC-1749794B0702 Q41869365-311BDA67-2C28-432C-8191-5D3C4EA7E4E1 Q46074545-D98BA7A0-123C-446D-9824-E8157963FEAD Q52709596-B853C52F-1082-416B-A6D1-1371CEDFF857 Q55512591-3011F827-4A85-42A2-9A14-30E16D626878 Q58720808-BBF095F3-DDAA-4340-B633-D52330182B45

P2860

Exploring metabolic dysfunction in chronic kidney disease.

http://www.wikidata.org/entity/Q36123347

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Exploring metabolic dysfunction in chronic kidney disease.

@ast

Exploring metabolic dysfunction in chronic kidney disease.

@en

type

label

Exploring metabolic dysfunction in chronic kidney disease.

@ast

Exploring metabolic dysfunction in chronic kidney disease.

@en

prefLabel

Exploring metabolic dysfunction in chronic kidney disease.

@ast

Exploring metabolic dysfunction in chronic kidney disease.

@en

P1433

Q36123347-C3B13FE9-57AC-4258-8774-B26F4BF51592

P1476

Q36123347-390953D1-DBAC-4A07-B6C1-6D0A3691C08D

P2093

Q36123347-00818B90-AB16-4078-88F1-153A0571D8F8

P2860

Q36123347-06387664-EAF2-4573-B4BC-E6AA3CA5D2F5

Q36123347-099F6D9B-265F-4EDD-8595-441BA8FF669E

Q36123347-09B8C46B-B928-4806-B2C6-645A41557AE2

Q36123347-0EF402CB-9345-4CE3-A17A-1FCE16E4AF8C

Q36123347-0F058509-0170-48DF-BCC2-B7D9DC8DA19B

Q36123347-10395FCA-DD22-466F-B305-E547871A73DA

Q36123347-11352E4F-E12F-41B7-8932-8A3745A42A3B

Q36123347-1401F127-4516-475B-B57D-AA00CCD41763

Q36123347-1596B0BA-340F-4100-9880-B5B2A075C0D7

Q36123347-15BF8B4A-D566-4312-8985-764C74BB9A95

P2888

Q36123347-3198AD1D-3677-4B97-B39B-19C96F59CCB1

P304

Q36123347-984B69FA-920F-42C0-9D60-889DCF7BD92E

P31

Q36123347-35DE7F81-1A20-4A5D-B4F4-69A8416B609C

P356

Q36123347-19029647-9027-4CFC-BF9C-25AC156B3EC4

P433

Q36123347-2E1D4A92-B212-4CD2-BD84-6EDD0D29D8D9

P478

Q36123347-BC8C4C3B-D01D-40B8-A120-A491923B2F01

P577

Q36123347-1EE99744-4B28-427C-A843-72684F7FDA55

P5875

Q36123347-E68660CE-5E51-4CE3-A35F-50BE2EE657EB

P6179

Q36123347-929E53AA-AB62-4BB3-9009-B6F65F7D8496

P698

Q36123347-0128B1B2-7478-473F-A27E-44E00BA68A78

P932

Q36123347-13A2ED0E-0C1C-4EFC-9A0E-1B61D94364AF

P356

P1433

Nutrition and Metabolism

P1476

Exploring metabolic dysfunction in chronic kidney disease.

@en

P2093

Adrian D Slee

http://www.w3.org/2001/XMLSchema#string

P2860

The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen

Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function

The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome

Metabolic syndrome and kidney disease: a systematic review and meta-analysis

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Chronic kidney disease and mortality risk: a systematic review

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function.

P2888

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1743-7075-9-36

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224854023

http://www.w3.org/2001/XMLSchema#string

P6179

1027382437

http://www.w3.org/2001/XMLSchema#string

P698

22537670

http://www.w3.org/2001/XMLSchema#string

P932

3407016

http://www.w3.org/2001/XMLSchema#string